A detailed history of Archer Investment Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Archer Investment Corp holds 476 shares of AZN stock, worth $35,328. This represents 0.01% of its overall portfolio holdings.

Number of Shares
476
Previous 476 -0.0%
Holding current value
$35,328
Previous $37.1 Million 15.9%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $153 - $175
2 Added 0.42%
476 $37.1 Million
Q2 2023

Aug 08, 2023

BUY
$69.91 - $75.81 $19,155 - $20,771
274 Added 137.0%
474 $33.9 Million
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $1,293 - $1,659
-30 Reduced 13.04%
200 $10,000
Q4 2019

Feb 20, 2020

BUY
$42.46 - $50.46 $8,492 - $10,092
200 Added 666.67%
230 $11,000
Q4 2018

Apr 06, 2020

BUY
$36.86 - $41.49 $1,105 - $1,244
30 New
30 $1,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $230B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.